Format

Send to

Choose Destination
Haematologica. 2016 Dec;101(12):e485-e487. Epub 2016 Aug 18.

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

Author information

1
University Hospital Heidelberg, Germany maximilian.merz@med.uni-heidelberg.de.
2
Asklepios Hospital Hamburg Altona, Germany.
3
Klinikum Chemnitz, Germany.
4
University Hospital Heidelberg, Germany.
5
National Center for Tumor Diseases Heidelberg, Germany.
6
German Cancer Research Center Heidelberg, Germany.
7
Charité Universitätsmedizin Berlin, Germany.
8
University Hospital Cologne, Germany.
9
Institute of Human Genetics, University of Heidelberg, Germany.
10
University Medical Center Mainz, Germany.
11
University Hospital Bonn, Germany.
12
Helios Hospital Berlin Buch, Germany.
13
Kath. Krankenhaus Hagen, Germany.
14
Asklepios Hospital St. Georg Hamburgy, Germany.
15
University Hospital Tübingen, Germany.
16
University Hospital Essen, Germany.
PMID:
27540135
PMCID:
PMC5479613
DOI:
10.3324/haematol.2016.151266
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center